A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B. (Q34515984)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B.
scientific article

    Statements

    A 12-week clevudine therapy showed potent and durable antiviral activity in HBeAg-positive chronic hepatitis B. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit